These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 36418784)
1. EQ-5D and SF-6D health utility scores in patients with spinal and bulbar muscular atrophy. Xu RH; Lu M; Zhang S; Dong D Eur J Health Econ; 2023 Nov; 24(8):1399-1410. PubMed ID: 36418784 [TBL] [Abstract][Full Text] [Related]
2. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis. Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061 [TBL] [Abstract][Full Text] [Related]
3. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population. Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301 [TBL] [Abstract][Full Text] [Related]
4. Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients. Wu J; Han Y; Zhao FL; Zhou J; Chen Z; Sun H Health Qual Life Outcomes; 2014 Oct; 12():156. PubMed ID: 25343944 [TBL] [Abstract][Full Text] [Related]
5. Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse. Harvie HS; Honeycutt AA; Neuwahl SJ; Barber MD; Richter HE; Visco AG; Sung VW; Shepherd JP; Rogers RG; Jakus-Waldman S; Mazloomdoost D; Am J Obstet Gynecol; 2019 Mar; 220(3):265.e1-265.e11. PubMed ID: 30471259 [TBL] [Abstract][Full Text] [Related]
6. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service. Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412 [TBL] [Abstract][Full Text] [Related]
7. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain. Cheung PWH; Wong CKH; Cheung JPY Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342 [TBL] [Abstract][Full Text] [Related]
8. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients. Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540 [TBL] [Abstract][Full Text] [Related]
9. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Petrou S; Hockley C Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis. Kwakkenbos L; Fransen J; Vonk MC; Becker ES; Jeurissen M; van den Hoogen FH; van den Ende CH Clin Exp Rheumatol; 2013; 31(2 Suppl 76):50-6. PubMed ID: 23910610 [TBL] [Abstract][Full Text] [Related]
11. EQ-5D-5L and SF-6Dv2 health utilities scores of diffuse large B-cell lymphoma patients in China. Li M; Fang B; Gu H; Jiang Y Health Qual Life Outcomes; 2024 Sep; 22(1):80. PubMed ID: 39300432 [TBL] [Abstract][Full Text] [Related]
12. Comparison of EuroQol-5D and short form-6D utility scores in multiethnic Asian patients with psoriatic arthritis: a cross-sectional study. Leung YY; Png ME; Wee HL; Thumboo J J Rheumatol; 2013 Jun; 40(6):859-65. PubMed ID: 23504382 [TBL] [Abstract][Full Text] [Related]
13. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis. Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661 [TBL] [Abstract][Full Text] [Related]
14. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation. Wong CKH; Lang BHH; Yu HMS; Lam CLK Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296 [TBL] [Abstract][Full Text] [Related]
15. A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD). Chen J; Wong CK; McGhee SM; Pang PK; Yu WC PLoS One; 2014; 9(11):e112389. PubMed ID: 25379673 [TBL] [Abstract][Full Text] [Related]
16. [Health Utility of Patients with Stroke Measured by EQ-5D and SF-6D]. Du XD; Zhu P; Li ME; Wang J; Meng HD; Zhu CR Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):252-257. PubMed ID: 29737071 [TBL] [Abstract][Full Text] [Related]
17. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure. Kontodimopoulos N; Argiriou M; Theakos N; Niakas D Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of Chinese medicine quality of life assessment scale (CQ-11D) and EQ-5D-5L and SF-6D scales based on Chinese population. Zhou J; Xu L; Pan J; Wang M; Zhou P; Wang W; Lu S; Zhu W Qual Life Res; 2024 Jan; 33(1):113-122. PubMed ID: 37695478 [TBL] [Abstract][Full Text] [Related]
19. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis. Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Walters SJ; Brazier JE Qual Life Res; 2005 Aug; 14(6):1523-32. PubMed ID: 16110932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]